Page last updated: 2024-08-24

thymidine 5'-triphosphate and Cancer of Rectum

thymidine 5'-triphosphate has been researched along with Cancer of Rectum in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brabender, J; Hoelscher, AH; Hoffmann, AC; Ling, F; Lurje, G; Metzger, R; Schneider, PM; Vallböhmer, D; Warnecke-Eberz, U1
Fischer, PH; Pangallo, CA; Van Mouwerik, TJ; Willson, JK1

Other Studies

2 other study(ies) available for thymidine 5'-triphosphate and Cancer of Rectum

ArticleYear
Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection.
    Journal of surgical oncology, 2009, Apr-01, Volume: 99, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Chemotherapy, Adjuvant; Dihydrouracil Dehydrogenase (NADP); Feasibility Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Pilot Projects; Postoperative Period; Radiotherapy, Adjuvant; Rectal Neoplasms; Regression Analysis; RNA, Messenger; ROC Curve; Sensitivity and Specificity; Survival Rate; Thymine Nucleotides

2009
Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole.
    Biochemical pharmacology, 1987, Mar-15, Volume: 36, Issue:6

    Topics: Cell Line; Cell Survival; Colonic Neoplasms; Dipyridamole; Drug Synergism; Guanine; Humans; Hypoxanthine; Hypoxanthines; Methotrexate; Rectal Neoplasms; Thymidine; Thymine Nucleotides

1987